Canilang, Baby Boy .
HRN: 25-29-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2024
AMPICILLIN 500MG (VIAL)
06/17/2024
06/24/2024
IVT
290mg
Q12
GI Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes